Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The drug name "usual pain treatment-St. Olavs Hospital-postoperative pain" refers to a specific multimodal analgesic regimen utilized as the standard of care at St. Olavs Hospital for managing postoperative pain, particularly following primary knee arthroplasty. This regimen is a combination of four distinct pharmacological agents: the corticosteroid dexamethasone, the non-opioid analgesic paracetamol (acetaminophen), and Vimovo, which is a fixed-dose combination of the non-steroidal anti-inflammatory drug (NSAID) naproxen and the proton pump inhibitor esomeprazole. The protocol involves a premedication phase with all four components, followed by postoperative maintenance with paracetamol and Vimovo. This combination targets multiple pain pathways: dexamethasone acts as a glucocorticoid receptor agonist to reduce systemic inflammation; paracetamol provides central analgesia; naproxen inhibits cyclooxygenase enzymes (COX-1 and COX-2) to reduce peripheral and central prostaglandin synthesis; and esomeprazole acts as an H+/K+ ATPase inhibitor to provide gastric protection against NSAID-induced mucosal injury.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on usual pain treatment-St. Olavs Hospital-postoperative pain.